Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of TQB3454 tablets in advanced solid tumors
CTR20262865Phase 2Active
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TQB3454 in Nonhematologic neoplasms, glioma, biliary cancer, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Aug 2026; status: active.
02
Drugs
TQB3454
03
Conditions
Nonhematologic neoplasmsgliomabiliary cancer
Beyond the preview
Go deeper on CTR20262865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262865.